Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT05408858
Eligibility Criteria:
Inclusion Criteria:
* 12-17 years old
* Self-identify as LGBTQ (any diverse sexual orientation and/or gender identity)
* Live in New York, New Jersey, or Connecticut
* Fluent in English
* Meet diagnostic criteria for a DSM-5 internalizing disorder (any depressive, anxiety, obsessive-compulsive, or adjustment disorder)
* Have consistent, weekly access to an Internet-enabled electronic device that allows for video-conferencing
* Availability to attend 10 weekly 90 minute intervention sessions in summer 2021
* Access to a quiet, private place for intervention sessions
* Provision of informed consent from parent/guardian and assent from the youth
Exclusion Criteria:
* Evidence of any psychotic or bipolar spectrum diagnosis
* Active suicidality and/or homicidality (defined as active intent or concrete plan, as opposed to passive ideation) or psychiatric hospitalization within the past 6 months
* Significant cognitive impairment (as determined by an intellectual disability screener) or significant developmental disorder (if impairing youth's ability to participate in group therapy)
* Significant behavior disorder (e.g., oppositional defiant disorder, conduct disorder) if impairing youth's ability to participate in group therapy
* Currently in mental health treatment exceeding one day per month
* Received any cognitive-behavioral therapy treatment in the past 12 months
* Unstable psychotropic medications (defined as changes to antidepressant dosage in the past 3 months, or changes to a benzodiazepine dosage in the past month)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
17 Years
Study:
NCT05408858
Study Brief:
Protocol Section:
NCT05408858